Browse studies
Find your next paid study
2 recruiting studies matching your filters
Phase 4
A Phase 4, Multicenter, Open-label Study to Evaluate Long-term Safety and Efficacy of Revakinagene Taroretcel-Lwey (NT-501) Previously Implanted During a Phase 1, Phase 2, or Phase 3 Clinical Study and to Evaluate NT-501 Implanted in Participants Who Underwent the Sham Procedure in a Phase 3 Clinical Study of Macular Telangiectasia Type 2 (MacTel)
The purpose of this global, multicenter, open-label, Phase 4 clinical extension study is to evaluate the long-term safety and efficacy of revakinagene taroretc…
Macular Telangiectasia Type 2 (MacTel)
Neurotech PharmaceuticalsNCT06971939
Phase 3
Phase 3 Study of Serine Supplementation to Protect Vision in MacTel
The goal of this clinical trial is to look at the efficacy and safety of giving oral serine (an amino acid) on the progression of structural and functional cha…
Macular Telangiectasia Type 2 (MacTel)
The Lowy Medical Research Institute LimitedNCT07342439